3Zeni F,Viallon A,Assicot M,et al.Procalcitonin serum concentrations and severity of sepsis[J].Clin Intens Care,1994,5 (suppl2):89-98.
4Anonymous.Americn college of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use innovative therapies in sepsis[J].Crit Care Med,1992,20:864-874.
5Bone RC.Definition for sepsis and organ failure[J].Crit Care Med,1992,19:973 -976.
6Hergert M,Lestin HG,Scherkus,et al.Proeacitonin in patients with sepsis and polytrauma[J].Cfin Lab,1998,44:659-670.
7Oberhoffer M,Bitterlich A,Hentsche,et al.Procacitonin correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response[J].Clin Intens Care,1996,22:A245.
8Gibot S,Cravoisy A,Kolopp-Sarda MN,et al.Time-course of sTREM (soluble triggering receptor expressed on myeloid cells) -1,procalcitonin,and C-reactive protein plasma concentrations during sepsis[J].Crit Care Med,2005,33 (4):792-796.
9Nylen E S,WhangK T,Snider T H,et al.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J].Crit Care Med,1998,26(6):1001 -1006.
10Dandona P,Nix D,Wilison MF,et al.Procacitonin increase after endotoxin injection in normal subjects[J].J Chin Endocrinol Metab,1994,79:1605-1608.
7Bone RC,Balk RA,Cetra FB,et al.Definitions for sepsis and organ failure and guideline for the use of innovation therapies in sepsis.The ACCP/SCCM Consensus Committee American College of Chest Physicians/Society of Care Medicine[J].Chest,1992,101(6):1644-1655.
